WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer
Citron, F.; Ho, I.-L.; Balestrieri, C.; Liu, Z.; Yen, E.-Y. N.; Cecchetto, L.; Perelli, L.; Zhang, L.; Castillo Montanez, L. A.; Blazanin, N.; Dyke, C. A.; Shah, R.; Attanasio, S.; Srinivasan, S.; Chen, K.-C.; Chen, Z.; Scognamiglio, I.; Pham, N.; Khan, H.; Jiang, S.; Pan, J.; Vanderkruk, B.; Leung, C.; Mattohti, M.; Rai, K.; Chu, Y.; Wang, L.; Gao, S.; Deem, A. K.; Carugo, A.; Wang, H.; Yao, W.; Tonon, G.; Xiong, Y.; Lorenzi, P. L.; Bonini, C.; Zal, A.; Hoffman, B.; Giuliani, V.; Heffernan, T.; Jeter, C. R.; Lissanu, Y.; Genovese, G.; Di Pilato, M.; Viale, A.; Draetta, G. F.
Show abstract
It is unclear how cells counteract the potentially harmful effects of uncoordinated DNA replication in the context of oncogenic stress. Here, we identify the WRAD (WDR5/RBBP5/ASH2L/DPY30) core as a modulator of DNA replication in pancreatic ductal adenocarcinoma (PDAC) models. Molecular analyses demonstrated that the WRAD core interacts with the replisome complex, with disruption of DPY30 resulting in DNA re-replication, DNA damage, and chromosomal instability (CIN) without affecting cancer cell proliferation. Consequently, in immunocompetent models, DPY30 loss induced T cell infiltration and immune-mediated clearance of highly proliferating cancer cells with complex karyotypes, thus improving anti-tumor efficacy upon anti-PD-1 treatment. In PDAC patients, DPY30 expression was associated with high tumor grade, worse prognosis, and limited response to immune checkpoint blockade. Together, our findings indicate that the WRAD core sustains genome stability and suggest that low intratumor DPY30 levels may identify PDAC patients who will benefit from immune checkpoint inhibitors.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer 96%
- GTP signaling links metabolism, DNA repair, and responses to genotoxic stress 96%
- Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia 96%
Similar papers in this journal
Similar papers in this journal
- Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer 96%
- The CoREST Repressor Complex Mediates Phenotype Switching and Therapy Resistance in Melanoma 96%
- Nemo-like kinase disrupts nuclear import and drives TDP43 mislocalization in ALS 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.